Northwest Biotherapeutics Stock Minimum Initial Investment
NWBO Stock | USD 0.27 0.01 3.85% |
Northwest Biotherapeutics fundamentals help investors to digest information that contributes to Northwest Biotherapeutics' financial success or failures. It also enables traders to predict the movement of Northwest OTC Stock. The fundamental analysis module provides a way to measure Northwest Biotherapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Northwest Biotherapeutics otc stock.
Northwest |
Northwest Biotherapeutics OTC Stock Minimum Initial Investment Analysis
Northwest Biotherapeutics' Minimum Initial Investment refers to minimum amount the fund family or category will require an investor to deposit to acquire the very first position in the fund or to open an account. In other words, Minimum Initial Investment is a guarantee that any investment from a purchaser of a fund meets the minimum requirement of the fund.
More About Minimum Initial Investment | All Equity Analysis
Minimum Initial Investment | = | First Fund Deposit |
Fund managers put minimum investment restrictions on fund investments in order to allow the fund to function properly. Minimum restrictions allow fund managers to regulate cash flows of the fund, while guarding it against random trades that may negatively affect fund strategy.
Competition |
Based on the recorded statements, Northwest Biotherapeutics has a Minimum Initial Investment of 0.0. This indicator is about the same for the Biotechnology average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).
Did you try this?
Run Idea Optimizer Now
Idea OptimizerUse advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |
All Next | Launch Module |
Northwest Fundamentals
Return On Asset | -1.26 | ||||
Profit Margin | 52.10 % | ||||
Operating Margin | (54.95) % | ||||
Current Valuation | 1.03 B | ||||
Shares Outstanding | 1.05 B | ||||
Shares Owned By Insiders | 10.04 % | ||||
Shares Owned By Institutions | 0.23 % | ||||
Number Of Shares Shorted | 14.14 M | ||||
Price To Earning | 58.17 X | ||||
Price To Sales | 858.96 X | ||||
Revenue | 1 M | ||||
Gross Profit | 1 M | ||||
EBITDA | 184.72 M | ||||
Net Income | 179.13 M | ||||
Cash And Equivalents | 9.43 M | ||||
Cash Per Share | 0.01 X | ||||
Total Debt | 25.16 M | ||||
Debt To Equity | (16.14) % | ||||
Current Ratio | 0.10 X | ||||
Book Value Per Share | (0.10) X | ||||
Cash Flow From Operations | (38.3 M) | ||||
Short Ratio | 13.54 X | ||||
Earnings Per Share | (0.06) X | ||||
Target Price | 5.0 | ||||
Number Of Employees | 19 | ||||
Beta | -0.0115 | ||||
Market Capitalization | 705.3 M | ||||
Total Asset | 40.16 M | ||||
Retained Earnings | (862.01 M) | ||||
Working Capital | (40.83 M) | ||||
Current Asset | 24.1 M | ||||
Current Liabilities | 64.93 M | ||||
Z Score | -0.6 | ||||
Net Asset | 40.16 M |
About Northwest Biotherapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Northwest Biotherapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Northwest Biotherapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Northwest Biotherapeutics based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Northwest Biotherapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Northwest Biotherapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Northwest Biotherapeutics will appreciate offsetting losses from the drop in the long position's value.Moving against Northwest OTC Stock
0.44 | EPRX | Eupraxia Pharmaceuticals | PairCorr |
0.34 | FRTX | Fresh Tracks Therapeutics | PairCorr |
0.34 | FBIOP | Fortress Biotech Pref | PairCorr |
The ability to find closely correlated positions to Northwest Biotherapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Northwest Biotherapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Northwest Biotherapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Northwest Biotherapeutics to buy it.
The correlation of Northwest Biotherapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Northwest Biotherapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Northwest Biotherapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Northwest Biotherapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in Northwest OTC Stock
Northwest Biotherapeutics financial ratios help investors to determine whether Northwest OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Northwest with respect to the benefits of owning Northwest Biotherapeutics security.